Retrospective case review of lamotrigine use for affective instability of borderline personality disorder

CNS Spectrums

Volumn 12, Issue 3, 2007, Pages 207-210

  Weinstein, Wendy ^a,b   Jamison, Katrina L ^c  

^a Buffalo Medical Group   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONAZEPAM; ESCITALOPRAM; FLUOXETINE; LAMOTRIGINE; PAROXETINE;

ADULT; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MEDICAL RECORD REVIEW; MENTAL INSTABILITY; NAUSEA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34147188459     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900020927     Document Type: Review

References (9)

1. Smith DJ, Muir WJ, Blackwood DH. Is borderline personality disorder part of the bipolar spectrum? Harv Rev Psychiatry. 2004;12:133-139.
2. Johnson DM, Shea MT, Yen S, et al. Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders Study. Compr Psychiatry. 2003;44:284-292.
3. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association; 2000.
4. American Psychiatric Association. Practice guidelines for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2001;158(suppl 10):1-52.
5. Preston GA, Marchant BK, Reimherr FW, Strong RE, Hedges DW. Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord. 2004;79:297-303.
6. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67:1-8.
7. Pinto OC, Akiskal HS. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. J Affect Disord. 1998;51:333-343.
8. Rizvi ST. Lamotrigine and borderline personality disorder. J Child Adolesc Psychopharmacol. 2002;12:365-366.
9. Tritt K, Nickel C, Lahmann C, et al. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol. 2005;19:287-291.